CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.560
0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM EDT
4.557
-0.003 (-0.07%)
After-hours: Apr 2, 2026, 7:31 PM EDT
CytomX Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$12.10
Upside
+165.35%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +163.16% | Mar 23, 2026 |
| Barclays | Barclays | Buy Maintains $10 → $16 | Buy | Maintains | $10 → $16 | +250.88% | Mar 19, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $8 → $16 | Strong Buy | Maintains | $8 → $16 | +250.88% | Mar 18, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $10 → $15 | Strong Buy | Maintains | $10 → $15 | +228.95% | Mar 18, 2026 |
| Wedbush | Wedbush | Buy Maintains $6 → $11 | Buy | Maintains | $6 → $11 | +141.23% | Mar 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $17 | Strong Buy | Maintains | $10 → $17 | +272.81% | Mar 16, 2026 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $7 → $12 | Hold → Buy | Upgrades | $7 → $12 | +163.16% | Mar 16, 2026 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +119.30% | Mar 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $6 → $10 | Buy | Maintains | $6 → $10 | +119.30% | Feb 4, 2026 |
| Barclays | Barclays | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +119.30% | Feb 4, 2026 |
| Barclays | Barclays | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +75.44% | Jan 20, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +119.30% | Jan 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $6.5 → $10 | Buy | Maintains | $6.5 → $10 | +119.30% | Jan 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +119.30% | Nov 11, 2025 |
| Barclays | Barclays | Buy Maintains $3.5 → $6 | Buy | Maintains | $3.5 → $6 | +31.58% | Oct 21, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $6 | Buy | Initiates | $6 | +31.58% | Sep 22, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.